|
CN104254323A
|
|
Soft elastic capsules containing tablets and liquid or semisolid fills and methods for their manufacture
|
|
US2014154311A1
|
|
Enteric soft capsules
|
|
MX2011006307A
|
|
Methods for enhancing the release and absorption of water insoluble active agents.
|
|
WO2010042499A1
|
|
Stable solutions of orlistat for pharmaceutical dosage forms
|
|
CA2627292A1
|
|
Hydrophilic vehicle-based dual controlled release matrix system
|
|
CN101351196A
|
|
Lipophilic vehicle-based dual controlled release matrix system serving as capsule fillers
|
|
US2007053868A1
|
|
Solvent system for enhancing the solubility of pharmaceutical agents
|
|
US2007148248A1
|
|
Gastric reflux resistant dosage forms
|
|
US2007082046A1
|
|
Enteric valproic acid
|
|
US2006088590A1
|
|
Non-blooming gelatin and non-gelatin formulations
|
|
US2006134190A1
|
|
Formulations of bisphosphonate drugs with improved bioavailability
|
|
US7887838B2
|
|
Non-gelatin film and method and apparatus for producing same
|
|
EP1496873A2
|
|
Chewable soft capsule
|
|
WO02072723A2
|
|
Gelatin manufacturing process and product
|
|
US6949256B2
|
|
Non-gelatin capsule shell formulation
|
|
AU3417802A
|
|
Nutritional supplement and method of use
|
|
US6685961B1
|
|
Colored gelatin-based formulations and method
|
|
US6251426B1
|
|
Ibuprofen-containing softgels
|
|
US6258380B1
|
|
Chewable soft capsule
|
|
US6193999B1
|
|
Gum acacia substituted soft gelatin capsules
|
